Viracept and Gastroenteritis - a phase IV clinical study of FDA data

Summary:

Gastroenteritis is reported as a side effect among people who take Viracept (nelfinavir mesylate), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Epivir, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Gastroenteritis when taking Viracept. It is created by eHealthMe based on reports of 6,392 people who have side effects when taking Viracept from the FDA, and is updated regularly.

What is Viracept?

Viracept has active ingredients of nelfinavir mesylate. It is often used in hiv infection. eHealthMe is studying from 6,399 Viracept users. Check the latest studies of Viracept.

What is Gastroenteritis?

Gastroenteritis (inflammation of stomach and intestine) is found to be associated with 1,360 drugs and 1,278 conditions by eHealthMe. Check the latest studies of Gastroenteritis.

On Jul, 12, 2026

6,392 people reported to have side effects when taking Viracept.
Among them, 24 people (0.38%) have Gastroenteritis.

Among these 24 people:

How long have people been on Viracept when they have Gastroenteritis? *

What is the gender of people who have Gastroenteritis when taking Viracept? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Gastroenteritis when taking Viracept? *

What are other drugs people take besides Viracept? *

What are other side effects people have besides Gastroenteritis? *

Hyperkalemia (damage to or disease of the kidney): 5 people, 20.83%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 4 people, 16.67%
Vitreous Haemorrhage (intraocular (inside the eye) bleeding): 4 people, 16.67%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 16.67%
Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 16.67%
Weakness: 3 people, 12.50%
Blood Lactic Acid Increased: 3 people, 12.50%
Blood Creatine Phosphokinase Increased: 3 people, 12.50%
Dehydration (dryness resulting from the removal of water): 3 people, 12.50%
Weight Decreased: 2 people, 8.33%

What are the existing conditions these people have? *

Vitreous Haemorrhage (intraocular (inside the eye) bleeding): 4 people, 16.67%
Ocular Hypertension (intraocular pressure higher than normal): 4 people, 16.67%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 16.67%
Hyperkalemia (damage to or disease of the kidney): 4 people, 16.67%
High Blood Pressure: 4 people, 16.67%
Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 16.67%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 4 people, 16.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 16.67%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 8.33%
Mycobacterium Avium Complex Infection: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Viracept and have Gastroenteritis?

- Check whether Gastroenteritis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Viracept:

Viracept (6,399 reports)

Gastroenteritis treatments and more:

Gastroenteritis (21,518 reports)

Browse all side effects of Viracept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gastroenteritis:

Gastroenteritis (1,360 drugs)

Browse all the conditions that are associated with Gastroenteritis:

Gastroenteritis (1,278 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nelfinavir mesylate (the active ingredients of Viracept) and Viracept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.